Barry Drew is a seasoned scientist with over 20 years of experience in analytical chemistry and drug development, currently serving as a QC Manager specializing in method transfer and validation at Pfizer. Past roles include Senior Scientist at Biogen and Bristol-Myers Squibb, where they led technical development and analytical agendas for various biotherapeutics. Barry earned a Ph.D. in Analytical/Physical Chemistry from the University of Missouri-Kansas City and holds a B.S. in Chemistry from the University of South Carolina. Their expertise spans multiple modalities, including monoclonal and bispecific antibodies, and they have a strong track record in team leadership and mentoring.
This person is not in the org chart
This person is not in any teams
This person is not in any offices